FDA Analgesic Safety Campaign Launches; Label Warnings Still In Progress

FDA launched a public educational campaign Jan. 22 warning consumers about the link between acetaminophen and liver damage, and potential renal and gastrointestinal problems associated with nonsteroidal anti-inflammatory use